Winton Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Winton Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,913	Closed	-$337K	–	1483
2021 Q3	$337K	Buy	+9,913	New	+$316K	0.02%	1049
2020 Q4	–	Sell	-13,580	Closed	-$697K	–	1553
2020 Q3	$697K	Sell	13,580 -17,822	-57%	-$873K	0.02%	971
2020 Q2	$1.88M	Buy	31,402 +15,841	+102%	+$847K	0.05%	687
2020 Q1	$641K	Sell	15,561 -3,056	-16%	-$170K	0.02%	962
2019 Q4	$1.16M	Buy	+18,617	New	+$885K	0.02%	1012

Other funds holding DCPH

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Winton Group's DCPH Position: Q4 2021 in Review

Winton Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 9,913 shares — an estimated $337K sold.

Winton Group first reported a position in DCPH in Q4 2019 and held it in 5 quarters. The position peaked at $1.88M in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Winton Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Winton Group sold 9,913 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $337K.
Winton Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Winton Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.88M in Q2 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.